Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
From Blue Chips to Banksy: Hear from Public.com CFO Live From NYSE
IPO Edge hosted a fireside chat from the New York Stock Exchange with Sruthi Lanka,...
REPLAY: Exploring Ocean Depths for EV Battery Metals: CEO, CFO of The Metals Co in Fireside
The ocean floor is home to a veritable treasure trove of critical metals needed for...
Vast Solar: A Carbon-Free Breakthrough for Utilities of the Future
Vast Solar going public via a merger with Nabors Energy Transition Corp. (NYSE: NETC) NETC...
Customized Treatments in Modern Medicine: Hear from Thirty Madison President and CFO Live from the NYSE Floor
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Fintech to Optimize Corporate Cards and Payments: Ramp VP of Finance & Capital Markets Live From NYSE Floor
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Keys to a Successful IPO: KPMG National Capital Markets Readiness Leader, Live From NYSE Floor
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Fighting Age-Related Disease: Hear from Cambrian Bio CFO & COO, Live From NYSE Floor
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
